Press release
August 14, 2026
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
60 Degrees Pharmaceuticals, Inc. (SXTP)
WASHINGTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne diseases, reported today its financial results for the second quarter of 2026, ended June 30, 2026.